BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
X-WR-CALNAME:Beyond the Initial Cure: Expanding Horizons of Orphan Drug Ind
 ications
X-WR-TIMEZONE:Pacific Time (US & Canada)
BEGIN:VEVENT
DTSTAMP:20260714T124113Z
UID:tag:localist.com\,2008:EventInstance_45873007204311
DTSTART:20240327T160000Z
DTEND:20240327T170000Z
DESCRIPTION:The Inflation Reduction Act stands as key legislation aimed at 
 improving the accessibility of medicines\, yet it has introduced some pote
 ntial unintended consequences on biotechnology innovation and patients suf
 fering from orphan diseases. In response\, the Orphan Cures Act has emerge
 d as a proposed bill dedicated to bolstering research and development for 
 rare diseases. This webinar will explore how these legislative efforts int
 ersect\, examining their impact on the delicate balance between innovation
 \, affordability\, and access in the realm of rare disease treatments.\n\n
 Speakers:\n\nMason Barrett\, Policy Analyst\, National Organization for Ra
 re Disorders (NORD)\n\nJon Brodo\, Policy Director\, Todd Strategy\n\nCart
 ier Esham\, PhD\, Chief Scientific Officer & EVP of Emerging Companies\, B
 iotechnology Innovation Organization (BIO)\n\nModerator:\n\nErika Modina\,
  MS\, 2023-25 Policy Fellow\, Stanford Byers Center for Biodesign
LOCATION:
SUMMARY:Beyond the Initial Cure: Expanding Horizons of Orphan Drug Indicati
 ons
URL;VALUE=URI:https://events.stanford.edu/event/beyond-the-initial-cure-exp
 anding-horizons-of-orphan-drug-indications
CATEGORIES:Lecture/Presentation/Talk
END:VEVENT
END:VCALENDAR